Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.

Pendyala L, Yin X, Li J, Shinke T, Xu Y, Chen JP, King SB 3rd, Colley K, Goodchild T, Chronos N, Hou D.

EuroIntervention. 2010 May;6(1):126-33. doi: 10.4244/.

PMID:
20542808
2.

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.

Segev A, Nili N, Osherov AB, Qiang B, Wong AJ, Pillarisetti S, Strauss BH.

EuroIntervention. 2010 May;6(1):134-40. doi: 10.4244/.

PMID:
20542809
3.

Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.

Sheehy A, Hsu S, Bouchard A, Lema P, Savard C, Guy LG, Tai J, Polyakov I.

Cardiovasc Diabetol. 2012 Jun 21;11:75. doi: 10.1186/1475-2840-11-75.

4.

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study.

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen JP, King SB 3rd, Chronos N, Eppihimer M, Huibregtse B, Dawkins KD, Hou D.

EuroIntervention. 2012 Aug;8(4):493-500. doi: 10.4244/EIJV8I4A77.

5.

Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.

Yang W, Ge J, Liu H, Zhao K, Liu X, Qu X, Li W, Huang Y, Sun A, Zou Y.

Cardiovasc Res. 2006 Dec 1;72(3):483-93. Epub 2006 Aug 23.

PMID:
17020754
6.

Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.

Jang HS, Nam HY, Kim JM, Hahm DH, Nam SH, Kim KL, Joo JR, Suh W, Park JS, Kim DK, Gwon HC.

Catheter Cardiovasc Interv. 2009 Nov 15;74(6):881-8. doi: 10.1002/ccd.22047.

PMID:
19496118
7.

Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.

Steigerwald K, Ballke S, Quee SC, Byrne RA, Vorpahl M, Vogeser M, Kolodgie F, Virmani R, Joner M.

EuroIntervention. 2012 Oct;8(6):752-9. doi: 10.4244/EIJV8I6A115.

8.

Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.

Shinke T, Geva S, Pendyala L, Jabara R, Li J, Chen JP, Venegoni A, Colley K, Klein R, Chronos N, Robinson K, Hou D.

Int J Cardiol. 2009 Jun 12;135(1):93-101. doi: 10.1016/j.ijcard.2008.06.030. Epub 2008 Aug 9.

PMID:
18692915
9.

In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.

Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Chan R, Su SH, Kolodgie F, Virmani R.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):429-36. doi: 10.1002/ccd.23407. Epub 2011 Dec 1.

PMID:
22105925
10.

Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.

van den Heuvel M, Sorop O, Batenburg WW, Bakker CL, de Vries R, Koopmans SJ, van Beusekom HM, Duncker DJ, Danser AH, van der Giessen WJ.

JACC Cardiovasc Interv. 2010 Jul;3(7):723-30. doi: 10.1016/j.jcin.2010.05.003. Erratum in: JACC Cardiovasc Interv. 2010 Sep;3(9):994.

11.

Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.

van Beusekom HM, Sorop O, van den Heuvel M, Onuma Y, Duncker DJ, Danser AH, van der Giessen WJ.

EuroIntervention. 2010 May;6(1):117-25. doi: 10.4244/.

PMID:
20542807
12.

Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.

John MC, Wessely R, Kastrati A, Schömig A, Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, Virmani R, Finn AV.

JACC Cardiovasc Interv. 2008 Oct;1(5):535-44. doi: 10.1016/j.jcin.2008.08.004.

14.

Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model.

Nakamura T, Brott BC, Brants I, Panchal D, Li J, Chen JP, King SB 3rd, Chronos N, Hou D.

JACC Cardiovasc Interv. 2011 Feb;4(2):247-55. doi: 10.1016/j.jcin.2010.08.028.

15.

A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.

Jia H, Liu H, Kong J, Hou J, Wu J, Zhang M, Tian J, Liu H, Ma L, Hu S, Huang X, Zhang S, Zhang S, Yu B, Jang IK.

J Biomed Mater Res A. 2011 Sep 15;98(4):629-37. doi: 10.1002/jbm.a.33151. Epub 2011 Jul 5.

PMID:
21732525
16.

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.

Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R.

Am J Cardiol. 2007 Oct 22;100(8B):36M-44M. Review.

PMID:
17950831
17.

Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.

Torella D, Curcio A, Gasparri C, Galuppo V, De Serio D, Surace FC, Cavaliere AL, Leone A, Coppola C, Ellison GM, Indolfi C.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2935-43. Epub 2007 Feb 9.

PMID:
17293493
18.

Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.

Clever YP, Cremers B, Krauss B, Böhm M, Speck U, Laufs U, Scheller B.

EuroIntervention. 2011 May;7 Suppl K:K32-42. doi: 10.4244/EIJV7SKA6.

PMID:
22027725
19.

Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.

Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G.

Kardiol Pol. 2010 May;68(5):503-9.

20.

Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.

Buszman PP, Milewski K, Zurakowski A, Pajak J, Jelonek M, Gasior P, Peppas A, Tellez A, Granada JF, Buszman PE.

Catheter Cardiovasc Interv. 2014 Feb;83(2):325-33. doi: 10.1002/ccd.24982. Epub 2013 Oct 23.

PMID:
23703720

Supplemental Content

Support Center